↓ Skip to main content

A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study

Overview of attention for article published in BMC Complementary and Alternative Medicine, July 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
42 Mendeley
Title
A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study
Published in
BMC Complementary and Alternative Medicine, July 2012
DOI 10.1186/1472-6882-12-96
Pubmed ID
Authors

Chiranjeev Dash, Fung-Lung Chung, Joy Ann Phillips Rohan, Emily Greenspan, Patrick D Christopher, Kepher Makambi, Yukihiko Hara, Kenneth Newkirk, Bruce Davidson, Lucile L Adams-Campbell

Abstract

Chemoprevention crossover trials of tea can be more efficient than parallel designs but the attrition and compliance rates with such trials are unknown.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
France 1 2%
Unknown 40 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 19%
Other 7 17%
Student > Bachelor 5 12%
Student > Ph. D. Student 5 12%
Unspecified 4 10%
Other 13 31%
Readers by discipline Count As %
Medicine and Dentistry 16 38%
Agricultural and Biological Sciences 6 14%
Unspecified 6 14%
Nursing and Health Professions 4 10%
Psychology 4 10%
Other 6 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2012.
All research outputs
#6,869,726
of 12,373,180 outputs
Outputs from BMC Complementary and Alternative Medicine
#1,032
of 2,511 outputs
Outputs of similar age
#47,268
of 98,082 outputs
Outputs of similar age from BMC Complementary and Alternative Medicine
#19
of 34 outputs
Altmetric has tracked 12,373,180 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,511 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.